Patterns of Initial Disease Recurrence after Resection of Biliary Tract Cancer
Authors:
- Sang Myung WooSWSang Myung Woo
- Hyung Ki ParkHPHyung Ki Park
- Woo Jin LeeWLWoo Jin Lee
- Mi Ah HanMHMi Ah Han
- Sung-Sik HanSHSung-Sik Han
- Seong Hoon KimSKSeong Hoon Kim
- Sang-Jae ParkSPSang-Jae Park
- Tae Hyun KimTKTae Hyun Kim
- Young Hwan KohYKYoung Hwan Koh
- Eun Kyung HongEHEun Kyung Hong
- 1 July 2012
- journal article
- Published by S. Karger AG in Oncology
- Vol. 83 (2) , 83-90
Abstract
Objectives: This study aimed to provide further insights into the indications for adjuvant therapeutic strategies via analysis of the sites of initial recurrence after resection of gallbladder cancer (GBC) and intrahepatic (IHC) and extrahepatic cholangiocarcinoma (EHC). Methods: Patients with biliary tract cancer who underwent potentially curative resection were identified from the database. Sites of initial disease recurrence were categorized as locoregional or distant. Results: Between March 2001 and April 2009, 231 patients underwent curative resection. Initial GBC and IHC recurrence involving a distant site occurred in 70.8 and 86.8% patients, respectively, compared to 56.9% patients with EHC (p = 0.002). The median time to disease recurrence (TTR) was shorter among the GBC and IHC groups compared with that in EHC patients (6.3 and 6.7 vs. 13.1 months, respectively; p = 0.003). Moreover, median times to distant recurrence in GBC and IHC groups were shorter than that in EHC (5.8 and 6.5 vs. 14.1 months, respectively; p = 0.002). Conclusions: After resection, recurrent GBC and IHC are more likely to involve a distant site and are associated with significantly shorter TTR than recurrent EHC. These findings suggest that an adjuvant therapeutic strategy targeting distant disease is likely to have a significant impact on the overall management of GBC and IHC.Keywords
This publication has 30 references indexed in Scilit:
- Concurrent Chemoradiotherapy in Resected Extrahepatic CholangiocarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in JapanJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Trends in Survival after Surgery for Cholangiocarcinoma: A 30-Year Population-Based SEER Database AnalysisJournal of Gastrointestinal Surgery, 2007
- A Multi-center Retrospective Analysis of Survival Benefits of Chemotherapy for Unresectable Biliary Tract CancerJapanese Journal of Clinical Oncology, 2007
- Adjuvant Concurrent Chemoradiation for Adenocarcinoma of the Distal Common Bile DuctInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Differential Cell Cycle–Regulatory Protein Expression in Biliary Tract Adenocarcinoma: Correlation With Anatomic Site, Pathologic Variables, and Clinical OutcomeJournal of Clinical Oncology, 2006
- Role of postoperative radiotherapy in the management of extrahepatic bile duct cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Worldwide trends in mortality from biliary tract malignanciesBMC Cancer, 2002
- Biliary Tract CancersNew England Journal of Medicine, 1999
- “Natural History” of Unresected Cholangiocarcinoma: Patient Outcome After Noncurative InterventionMayo Clinic Proceedings, 1995